| Cover | Feb. 13, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Feb. 13, 2024 |
| Entity File Number | 001-40388 |
| Entity Registrant Name | ANEBULO PHARMACEUTICALS, INC |
| Entity Central Index Key | 0001815974 |
| Entity Tax Identification Number | 85-1170950 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | Anebulo Pharmaceuticals, Inc. |
| Entity Address, Address Line Two | 1017 Ranch Road 620 South |
| Entity Address, Address Line Three | Suite 107 |
| Entity Address, City or Town | Lakeway |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 78734 |
| City Area Code | (512) |
| Local Phone Number | 598-0931 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $.0.001 par value per share |
| Trading Symbol | ANEB |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
